Hatteras Investment Partners’s Calumet Specialty Products CLMT Stock Holding History

Hatteras Investment Partners’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-18,191	Closed	-$437K	–	113
2015 Q1	$437K	Sell	18,191 -57,280	-76%	-$1.45M	0.23%	103
2014 Q4	$1.69M	Buy	+75,471	New	+$1.96M	0.61%	48

Other funds holding CLMT

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

SCVF

Small Cap Value Fund Dallas, Texas $538M AUM

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

SOAMC

Spirit of America Management Corp Syosset, New York $530M AUM 36.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TFMS

Trust & Fiduciary Management Services Boston, Massachusetts $126M AUM 9.97% 1-Year Est. Return

Hatteras Investment Partners's CLMT Position: Q2 2015 in Review

Hatteras Investment Partners sold out of Calumet Specialty Products (CLMT) in Q2 2015, closing a stake of 18,191 shares — an estimated $437K sold.

Hatteras Investment Partners first reported a position in CLMT in Q4 2014 and held it in 2 quarters. The position peaked at $1.69M in Q4 2014. 113 funds tracked by Wall St. Rank hold CLMT as of Q2 2015.

Hatteras Investment Partners reported no remaining Calumet Specialty Products position as of Q2 2015 after selling out during the quarter.
Hatteras Investment Partners sold 18,191 Calumet Specialty Products shares in Q2 2015, an estimated $437K.
Hatteras Investment Partners first reported a position in Calumet Specialty Products in Q4 2014 and held it in 2 quarters.
Hatteras Investment Partners's Calumet Specialty Products position peaked at $1.69M in Q4 2014.
113 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2015.

Based on Hatteras Investment Partners's 13F filing for Q2 2015, filed 13 Aug 2015.